Home›Companies›Healthcare›Ocudyne

Ocudyne, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 6, 2025·Suggest an edit

About Ocudyne

Ocudyne is a private company based in Brooklyn Park, Minnesota. It has reported $10,085,890 raised in five offerings on Form D since October 2013. Its chief executive is Jeffrey Franco.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 20, 2025Mar 6, 2025$5,727,496of $12.1M target8$715KEquityRule 506(b)Form D ↗
Jan 28, 2019Feb 11, 2019$2,008,975of $3.1M target1$2.0MEquityRule 506(b)Form D ↗
Aug 10, 2017Aug 22, 2017$886,483of $1.4M target6$147KEquityRule 506(b)Form D ↗
Oct 5, 2016Oct 20, 2016$462,967of $500K target5$92,593DebtRule 506(b)Form D ↗
Oct 17, 2013Oct 30, 2013$999,969of $1.0M target9$111KEquityRule 506(c)Form D ↗
Total, five offerings$10,085,890

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ocudyne's Form D filed Mar 6, 2025.

JS
Joseph Smith
Director
JF
Jeffrey Franco
Chief Executive Officer and director
JT

Earlier filings also listed Robert Atkinson (executive officer and director, last listed Feb 2019) and Edward Malouf (director, last listed Oct 2013).

Sources

  1. SECOcudyne, Inc. filing history